Literature DB >> 1972159

The human antimurine xenogeneic cytotoxic response. I. Dependence on responder antigen-presenting cells.

P J Lucas1, G M Shearer, S Neudorf, R E Gress.   

Abstract

We have examined the role of the human responder APC in the generation of CTL responses to xenogeneic antigens. Of six xenogeneic responses evaluated, only the human antimurine response was dependent on human APC for CTL generation. APC requirements for the other five xenogeneic responses more closely resembled those observed in the generation of human or murine alloreactive CTL. Depletion studies identified a defective human CD4+ Th cell-murine stimulator cell interaction that could be bypassed by the addition of exogenous IL-2. The function of the responder APC involved in the human antimurine CTL response was inhibited by chloroquine, suggesting a requirement for Ag processing. Effective presentation of murine stimulator Ag by human APC was completely blocked by anti-human Ia mAb, indicating that the Ag is presented to Th cells via the human class II molecule. These results are consistent with an Ia-dependent recognition of processed murine Ag by human T cells and represents a model for investigating human T cell activation requirements, Th cell function, and MHC restriction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972159

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Demonstration of direct xenorecognition of porcine cells by human cytotoxic T lymphocytes.

Authors:  A C Cunningham; T J Butler; J A Kirby
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

2.  Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.

Authors:  Bruno Nervi; Michael P Rettig; Julie K Ritchey; Hanlin L Wang; Gerhard Bauer; Jon Walker; Mark L Bonyhadi; Ronald J Berenson; Julie L Prior; David Piwnica-Worms; Jan A Nolta; John F DiPersio
Journal:  Exp Hematol       Date:  2007-08-30       Impact factor: 3.084

3.  Specific tolerance across a discordant xenogeneic transplantation barrier.

Authors:  L A Lee; H A Gritsch; J J Sergio; J S Arn; R M Glaser; T Sablinski; D H Sachs; M Sykes
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

4.  Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.

Authors:  Y Nishimura; M Eto; T Maeda; K Hiromatsu; N Kobayashi; K Nomoto; Y Y Kong; K Nomoto
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

5.  Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction.

Authors:  M S Lee; L Wogensen; J Shizuru; M B Oldstone; N Sarvetnick
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

Review 6.  Mouse models of graft-versus-host disease: advances and limitations.

Authors:  Mark A Schroeder; John F DiPersio
Journal:  Dis Model Mech       Date:  2011-05       Impact factor: 5.758

7.  NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models.

Authors:  Stefano Baldoni; Loredana Ruggeri; Beatrice Del Papa; Daniele Sorcini; Francesco Guardalupi; Francesca Ulbar; Andrea Marra; Erica Dorillo; Arianna Stella; Raffaella Giancola; Bianca Fabi; Rosaria Sola; Sara Ciardelli; Filomena De Falco; Chiara Rompietti; Francesco Maria Adamo; Emanuela Rosati; Antonio Pierini; Carlo Sorrentino; Paolo Sportoletti; Mauro Di Ianni
Journal:  Bone Marrow Transplant       Date:  2021-04-19       Impact factor: 5.174

8.  Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performance.

Authors:  Hilit Levy-Barazany; Liat Shachnai-Pinkas; Tsila Zuckerman; Jerry Stein; Galina Rodionov; Alex Saar; Michal Rosenzwaig; Liron Gez; Anastasia Rodin; Nitzan Marelly; Michal Abraham; Inbal Mishalian; Hila Wildbaum; Tamar Katz; Yuval Baar; Shai Yarkoni; Ronit Bakimer-Kleiner; Amnon Peled
Journal:  Bone Marrow Transplant       Date:  2020-05-20       Impact factor: 5.483

9.  Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease.

Authors:  John Wilson; Hannah Cullup; Rohan Lourie; Yonghua Sheng; Anna Palkova; Kristen J Radford; Anne M Dickinson; Alison M Rice; Derek N J Hart; David J Munster
Journal:  J Exp Med       Date:  2009-01-26       Impact factor: 14.307

10.  Allospecific Tregs Expanded After Anergization Remain Suppressive in Inflammatory Conditions but Lack Expression of Gut-homing Molecules.

Authors:  Eleni Kotsiou; John G Gribben; Jeff K Davies
Journal:  Mol Ther       Date:  2016-04-06       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.